Curie Capital
Investor profile
Venture capital
Curie Capital has backed 3 European tech companies across 3 funding rounds between 2022 and 2024, joining rounds totalling €163M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2022–2024
3 yrs
Total round €
€163M
sum of rounds joined
Deals by year
distinct rounds / yearCurie Capital — deals by year — interactive chart.
Data table
| Curie Capital — deals by year | |
|---|---|
| 2022 | 2 |
| 2024 | 1 |
Top sectors
by dealsCurie Capital — top sectors — interactive chart.
Data table
| Curie Capital — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsCurie Capital — stages — interactive chart.
Data table
| Curie Capital — stages | |
|---|---|
| Series A | 2 |
| Series B | 1 |
Countries
by dealsCurie Capital — countries — interactive chart.
Data table
| Curie Capital — countries | |
|---|---|
| Netherlands | 3 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Citryll | Netherlands | 1 | €85M |
| TargED Biopharmaceutical | Netherlands | 1 | €39M |
| TargED Biopharmaceuticals | Netherlands | 1 | €39M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Citryll | Series B | €85M | 2024-12 |
| TargED Biopharmaceutical | Series A | €39M | 2022-02 |
| TargED Biopharmaceuticals | Series A | €39M | 2022-02 |